A randomised, double-blind, placebo-controlled trial to assess the effects of EP395 following an inhaled endotoxin challenge in healthy adults
EP395-006
Phase 1 other active
Quick answer
A randomised, double-blind, placebo-controlled trial to assess the effects of EP395 following an inhaled endotoxin challenge in healthy adults for Healthy volunteers [targeted indication: chronic obstructive pulmonary disease (COPD)] is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Healthy volunteers [targeted indication: chronic obstructive pulmonary disease (COPD)]
- Phase
- Phase 1
- Modality
- other
- Status
- active